Le Lézard
Classified in: Health
Subjects: PSF, STP

Pennsylvania Physician General and Dauphin County Coroner Discuss Benzodiazepine Prescribing Guidelines


HARRISBURG, Pa., May 16, 2017 /PRNewswire-USNewswire/ -- Physician General Dr. Rachel Levine met with Dauphin County Coroner Graham Hetrick to discuss the Wolf Administration's prescribing guidelines for opioids and benzodiazepines and the opioid epidemic's devastating effects on Pennsylvanians.

"The combination of opioid painkillers with a benzodiazepine medications, like Xanax or Valium, can be deadly," said Dr. Levine. "With Governor Wolf's leadership, we are working with medical professionals to protect Pennsylvanians from the risk of overdose to save lives and make our communities safer. I thank Coroner Hetrick and his team for helping us spread this message."

Benzodiazepines, sometimes called "benzos," can be prescribed for treating aliments such as panic disorder, insomnia, and seizures. When used in conjunction with opioids, studies find that the chances for an accidental drug overdose increase.

Working with the Department of Drug and Alcohol Programs, the Department of Health has created a set of evidence-based, specialty-specific opioid prescribing guidelines to encourage judicious prescribing of the medication and reduce the number of opioids in distribution. The departments have completed the following guidelines:

"As coroner, I see far too often the deadly and devastating effects of the opioid epidemic," said Coroner Hetrick. "The disease of addiction takes lives and destroys families. With compassion, team work, and practicality, we aim to break the malicious grip addiction has on so many of our neighborhoods."

The Wolf Administration holds the fight against heroin and prescription opioids as a top priority.  To continue the battle against the opioid epidemic in Pennsylvania, Governor Wolf included the following proposals in his 2017-18 budget:

Some of the administration's other initiatives to fight the opioid epidemic include:

The main function of the Dauphin County Coroner's office is to determine the cause and manner of death in cases where the death is determined to fall under coroner jurisdiction. The coroner's office investigators and staff treat each death with respect, dignity, and kindness.

If you or someone you know is suffering from the disease of addiction, call 1-800-662-HELP or visit www.pa.gov/opioids for treatment options. For more information on the fight against opioid abuse in Pennsylvania, visit the Department of Health website at www.health.pa.gov or follow us on Facebook and Twitter.

MEDIA CONTACT: April Hutcheson, 717-787-1783 or [email protected]

SOURCE Pennsylvania Department of Health


These press releases may also interest you

at 03:12
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....

at 03:05
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for...

at 03:00
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, today announces the completion of a $120m Series B financing to fund the development of its...

at 03:00
YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A financing round of ?15 million from an Austrian private trust. The proceeds will be used to further...

at 02:59
Allied Market Research has recently published a report, titled, "Biometric Cards Market Size, Share, Competitive Landscape and Trend Analysis...

at 02:05
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and...



News published on and distributed by: